2024-10-18 - Analysis Report
## Philip Morris International Inc. (PM) Stock Analysis

**Company Overview:** Philip Morris International Inc. is a leading multinational tobacco company, producing and selling cigarettes and other nicotine products globally.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return (PM):** 28.57%
* **Cumulative Return (VOO):** 136.93%
* **Relative Divergence:** -108.36 (7.22% of the total range)

This shows PM has significantly underperformed the S&P 500 (VOO) over the period analyzed. It's lagging behind the market by a significant margin.

**2. Recent Price Movements:**

* **Closing Price:** $120.89
* **5-Day Moving Average:** $120.25
* **20-Day Moving Average:** $120.19
* **60-Day Moving Average:** $119.95

The stock price is currently trading above all moving averages, suggesting potential upward momentum.

**3. Technical Indicators:**

* **RSI:** 50.26 - Neutral, not oversold or overbought.
* **PPO:** 0.01 - Close to neutral, indicating a possible shift in trend.
* **Delta_Previous_Relative_Divergence:** -5.57 - Short-term downtrend.
* **Expected_Return:** 0.0% - Over a 5-year period, based on current market conditions and historical performance, the stock is not expected to outperform the S&P 500 significantly.

**4. Recent Earnings and Outlook:**

| Date       | EPS     | Revenue |
|------------|---------|---------|
| 2024-07-25 | 1.54    | 9.47 B$ |
| 2024-04-26 | 1.38    | 8.79 B$ |
| 2023-10-26 | 1.32    | 9.14 B$ |
| 2023-07-27 | 1.01    | 8.97 B$ |
| 2024-07-25 | 1.01    | 8.97 B$ |

The most recent earnings (2024-07-25) beat analysts' expectations, with EPS of 1.54 exceeding the forecast of 1.48. Revenue also came in higher than expected at 9.47 B$ against the forecast of 9.41 B$. This indicates positive performance and potential growth.

**5. News and Recent Issues:**

* **FINBOLD** reports that PM is facing challenges related to the decline in cigarette smoking globally and increasing regulatory scrutiny.
* **Analysts** have mixed opinions on PM. Some see potential for growth in emerging markets and the development of new, less harmful nicotine products, while others are concerned about the long-term impact of declining smoking rates and regulatory risks.

**6. Overall Analysis:**

PM has significantly underperformed the S&P 500 over the period analyzed, with a weaker relative divergence. However, recent price movements and positive earnings suggest potential upward momentum. Technical indicators are neutral, but with a short-term downtrend. Analysts have mixed opinions on the company's future prospects, with some expressing optimism about growth in emerging markets and new products, while others are concerned about declining smoking rates and regulatory challenges.  The company's recent earnings beat analysts' expectations, suggesting positive performance. 

**7. Conclusion:**

While PM has faced challenges in recent years, the company's recent earnings and market performance suggest potential for growth. However, the company is facing headwinds from declining smoking rates and increasing regulatory scrutiny. Investors should carefully consider these factors before making investment decisions. The stock may be suitable for investors with a long-term outlook and a tolerance for risk. 
